We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
-16.25%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.63B
AUM Growth
-$758M
Cap. Flow
-$358M
Cap. Flow %
-22.01%
Top 10 Hldgs %
47.54%
Holding
408
New
22
Increased
69
Reduced
110
Closed
53

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$21.2M
2
LLY icon
Eli Lilly
LLY
+$19.2M
3
MCD icon
McDonald's
MCD
+$9.1M
4
DHI icon
D.R. Horton
DHI
+$8.44M
5
LIN icon
Linde
LIN
+$8.43M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$53.8M
2
UPS icon
United Parcel Service
UPS
+$49.1M
3
PANW icon
Palo Alto Networks
PANW
+$48.1M
4
GS icon
Goldman Sachs
GS
+$45.4M
5
CVX icon
Chevron
CVX
+$41.4M

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Industrials 17.87%
3 Healthcare 12.42%
4 Consumer Discretionary 9.18%
5 Consumer Staples 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLRY icon
401
Tilray
TLRY
$598M
-1,801
Closed -$140K
TRV icon
402
Travelers Companies
TRV
$79.7B
-1,140
Closed -$208K
UBER icon
403
Uber
UBER
$137B
-7,700
Closed -$275K
VOOV icon
404
Vanguard S&P 500 Value ETF
VOOV
$6.7B
-2,520
Closed -$380K
WMB icon
405
Williams Companies
WMB
$87.7B
-6,075
Closed -$203K
VNE
406
DELISTED
Veoneer, Inc.
VNE
-8,000
Closed -$296K
SBNY
407
DELISTED
Signature Bank
SBNY
-107,909
Closed -$31.7M

Similar funds

R.H. Bluestein & Co's Q2 2022 Portfolio in Review

As of Q2 2022, R.H. Bluestein & Co held 408 positions worth $1.63B, down 32% from $2.39B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

R.H. Bluestein & Co withdrew a net $358M in Q2 2022, closing 53 positions and reducing 110 holdings. Its most notable exit was Goldman Sachs, an estimated $45.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, R.H. Bluestein & Co opened a new position in Eli Lilly worth $20.7M.

  • R.H. Bluestein & Co's largest Q2 2022 buy was Eli Lilly: 63,984 shares worth $20.7M.
  • R.H. Bluestein & Co added most to Analog Devices in Q2 2022, an estimated $21.2M increase.
  • R.H. Bluestein & Co's biggest Q2 2022 reduction was Home Depot, cutting an estimated $53.8M.
  • R.H. Bluestein & Co fully exited Goldman Sachs in Q2 2022, selling an estimated $45.4M.
  • R.H. Bluestein & Co's ten largest holdings make up 48% of its $1.63B portfolio in Q2 2022.
  • R.H. Bluestein & Co opened 22 new positions and closed 53 in Q2 2022.
  • R.H. Bluestein & Co's portfolio value fell 32% quarter-over-quarter to $1.63B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2022, filed 11 Aug 2022.